Multiplex Detection of Infectious Diseases on Microfluidic Platforms
Biosensors · 21.03.2023 · 13 (3) · 410
DOI: 10.3390/bios13030410 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 21.03.2023. Verfasst von Fumin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, No. 227 Chongqing South Roa…. Hauptthemen laut MEDLINE: Biosensing Techniques, Nucleic Acids, Communicable Diseases. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Infectious diseases contribute significantly to the global disease burden. Sensitive and accurate screening methods are some of the most effective means of identifying sources of infection and controlling infectivity. Conventional detecting strategies such as quantitative polymerase chain reaction (qPCR), DNA sequencing, and mass spectrometry typically require bulky equipment and well-trained personnel. Therefore, mass screening of a large population using conventional strategies during pandemic periods often requires additional manpower, resources, and time, which cannot be guaranteed in resource-limited settings. Recently, emerging microfluidic technologies have shown the potential to replace conventional methods in performing point-of-care detection because they are automated, miniaturized, and integrated. By exploiting the spatial separation of detection sites, microfluidic platforms can enable the multiplex detection of infectious diseases to reduce the possibility of misdiagnosis and incomplete diagnosis of infectious diseases with similar symptoms. This review presents the recent advances in microfluidic platforms used for multiplex detection of infectious diseases, including microfluidic immunosensors and microfluidic nucleic acid sensors. As representative microfluidic platforms, lateral flow immunoassay (LFIA) platforms, polymer-based chips, paper-based devices, and droplet-based devices will be discussed in detail. In addition, the current challenges, commercialization, and prospects are proposed to promote the application of microfluidic platforms in infectious disease detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, No. 227 Chongqing South Road, Shanghai 200025, China.
- One Health Center, Shanghai Jiao Tong University-The University of Edinburgh, Shanghai 200025, China.
- Department of Surgery, Division of Surgery Research, Mayo Clinic, Rochester, MN 55905, USA.
- Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Fumin Chen, Yi Xie, Yuqian Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
Zitieren
APA
Chen, F., Hu, Q., Li, H., Xie, Y., Xiu, L., Zhang, Y., Guo, X., & Yin, K. (2023). Multiplex Detection of Infectious Diseases on Microfluidic Platforms. Biosensors, 13(3), 410. https://doi.org/10.3390/bios13030410
Vancouver
Chen F, Hu Q, Li H, Xie Y, Xiu L, Zhang Y, et al. Multiplex Detection of Infectious Diseases on Microfluidic Platforms. Biosensors. 2023;13(3):410. doi:10.3390/bios13030410
BibTeX
@article{Chen2023,
author = {Chen, Fumin and Hu, Qinqin and Li, Huimin and Xie, Yi and Xiu, Leshan and Zhang, Yuqian and Guo, Xiaokui and Yin, Kun},
title = {Multiplex Detection of Infectious Diseases on Microfluidic Platforms},
journal = {Biosensors},
year = {2023},
volume = {13},
number = {3},
pages = {410},
doi = {10.3390/bios13030410}
}
EUVIMED